Login to Your Account

Gilead 2Q Sales Grow 14%

Amgen Serves Up Solid Q2 on Sales, Takeda Payment

By Jennifer Boggs and Marie Powers
Staff Writers

Friday, July 27, 2012
Amgen Inc.'s second-quarter figures blasted past expectations, as the Thousand Oaks, Calif.-based firm reported after market close Thursday total revenues of $4.5 billion, with adjusted earnings per share of $1.83, compared to consensus estimates of $4.1 billion and $1.54 per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription